Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Triple-Blind, Randomized Controlled Trial Evaluating Duloxetine on Post-Operative Outcomes Following Primary Total Knee Arthroplasty in Patients With and Without Central Sensitization

NCT05086393 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT05086393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05086393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Triple-Blind, Randomized Controlled Trial Evaluating Duloxetine on Post-Operative Outcomes Following Primary Total Knee Arthroplasty in Patients With and Without Central Sensitization
Lead sponsor
Rush University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2021
Completion date
July 23, 2025
Enrollment
241 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative, total knee arthroplasty